Overall survival of CyBorD- and DaraCyBorD-treated patients according to Mayo 2004 and 2012 staging. (A-B) Kaplan-Meier curves for OS for patients in the CyBorD (A) or DaraCyBorD (B) cohort stratified according to the Mayo 2012 staging system. (C-D) Kaplan-Meier curves for OS for patients in the CyBorD (C) or DaraCyBorD (D) cohort stratified according to the Mayo 2004 staging system with European modification.